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Abstract: Legume seeds are rich sources of protein, fiber, and minerals. In addition, their
phenolic compounds as secondary metabolites render health benefits beyond basic nutrition.
Lowering apolipoprotein B secretion from HepG2 cells and decreasing the level of low-density
lipoprotein (LDL)-cholesterol oxidation are mechanisms related to the prevention of cardiovascular
diseases (CVD). Likewise, low-level chronic inflammation and related disorders of the immune system
are clinical predictors of cardiovascular pathology. Furthermore, DNA-damage signaling and repair
are crucial pathways to the etiology of human cancers. Along CVD and cancer, the prevalence of obesity
and diabetes is constantly increasing. Screening the ability of polyphenols in inactivating digestive
enzymes is a good option in pre-clinical studies. In addition, in vivo studies support the role of
polyphenols in the prevention and/or management of diabetes and obesity. Soybean, a well-recognized
source of phenolic isoflavones, exerts health benefits by decreasing oxidative stress and inflammation
related to the above-mentioned chronic ailments. Similar to soybeans, chickpeas are good sources of
nutrients and phenolic compounds, especially isoflavones. This review summarizes the potential
of chickpea as a substitute for soybean in terms of health beneficial outcomes. Therefore, this
contribution may guide the industry in manufacturing functional foods and/or ingredients by using
an undervalued feedstock.
Keywords: legume seeds; genetics; phenolic antioxidants; inflammation; cardiovascular disease;
cancer; diabetes; obesity
1. Introduction
Legumes are a staple food with considerable importance for human nutrition due to their high
content of carbohydrates and proteins, especially when diets are plant-based or have restrictions
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to animal-based products [1]. Historical evidence suggests soybean as a domesticated species that
originated in Northeast China between 6000 and 9000 years ago [2,3]. The cultivated soybean
(Glycine max) is considered to have evolved from the wild species Glycine soja [4] and from the
transitional evolutionary species Glycine gracilis, which is considered a landrace [5]. Xu et al. [6]
reported that cultivated soybean with different cpDNA haploytypes originated independently in
different zones from different wild gene pools and/or hybrid swarms between wild and cultivated
genotypes, evidencing major gene flow from G. soja to G. gracilis and the latter to G. max, with moderate
gene contribution from G. soja to G. max [5,7,8]. The oldest records of soybean cultivation appear in
bronze inscriptions and in early writings that date not much earlier than 1100 BC. With the expansion
of the Shang dynasty, trade of soybean migrated to South China, Korea, Japan, and South East Asia,
where it progressively became a dietary staple [9]. Soybean was introduced to Europe in about 1691,
although it became a known food plant only in the 18th century. The introduction of soybean from
Europe to the USA occurred around 1804, when its utilization rapidly spread out to the rest of the
western world, especially in the 20th century [10]. According to Food and Agriculture Organization
(FAO), world production of soybeans is currently around 352.6 million tons, associated to 123.6 million
hectares grown globally, with average yields of 3.1 t/ha in 2017, and is presently a major crop in the
United States, Brazil, Argentina, India, and China, and the most important legume crop cultivated in
the world [11]. In Chile, national soybean production is only for seed exports and not for domestic
consumption, and being a secondary producer of this crop worldwide, the cultivated area was 1458 ha
of herbicide-tolerant transgenic soybeans in 2017 [12].
Chickpea (Cicer arietinum) is the only cultivated species in the genus Cicer, and it has never been
found in the wild but in the closely related taxa [13]. Recently, Cicer reticulatum has been postulated to
be the wild progenitor of modern chickpea [13,14]. The area of present-day southeastern Turkey and
adjoining Syria is the most probable center of origin of chickpea, which was domesticated with wheat,
barley, peas, and lentil as a member of West Asian Neolithic crops during the origin of agriculture around
10,000 years ago in the Fertile Crescent [15], with the oldest available archaeological evidence of chickpea
from 7500 BC [16,17]. It is considered to have spread throughout the Mediterranean area about 6000 years
ago and to have reached India about 4000 years ago [10], and then to the rest of the world. In chickpea,
a particular and drastic narrowing of genetic diversity during domestication has occurred due to a series of
bottlenecks unique to this crop [17]. Consequently, chickpea displays a lack of adaptive diversity for an
assortment of biotic and abiotic stresses [18]. Unlike cultivated chickpea, wild Cicer spp. possess useful
variation for several of those traits [19–21]. Globally, it is currently cultivated in over 14.5 million ha with an
annual production of 14.8 million tons and productivity of around 1 t/ha in 2017 [11], which is very much
lower than the estimated potential of 6 t/ha under optimum growing conditions [14]. The top chickpea
producing countries in the world are India, Australia, Pakistan, Turkey, and Mexico [11]. In Chile, chickpea
is a marginal crop, yielding on average 0.86 t/ha and a surface grown of 409 ha, which is mainly cultivated
in the rainfed area of Central Chile, according to the data of the 2015/2016 season [22].
In plants, phenolic compounds are responsible for a plethora of functions, including structural
components, UV protection, and antioxidant, signaling, and defense molecules [23]. Lignins and lignans
are the phenolic polymers that compose the plant secondary cell wall, giving the physical structure
and being tightly related to the growth of different plant parts, mostly stem, roots, and seeds [24].
These polymers are responsible for providing a protective barrier against herbivores, fungi, bacteria,
and virus, as well as forming an intricate network of biochemical compounds that play scavenger roles
of reactive oxygen species (ROS), antimicrobials, and wound signaling [25–27]. Moreover, hydrolyzable
tannins are known anti-herbivory molecules, which act by precipitating proteins of the digestive tract
of insects, impairing enzyme functions while reducing the digestibility of the ingested proteins [28].
The phenolic acids are important signaling molecules in plant-microbe interactions, for example,
salicylic acid, and can improve nutrient uptake and protect against infections [29]. Flavonoids are the
main source of plants non-enzymatic antioxidant apparatus; they provide a UV screen effect and play
a central role in scavenging ROS derived from photorespiration in high light conditions as well as in
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low/high-temperature stresses or other oxidative stresses [30]. In addition, anthocyanins display a
visual effect of colors ranging from yellow/orange to purple/bluish, which function as an important
mechanism of attraction of pollinators and seed dispersers [31–33].
Food macronutrients play a crucial role in human nutrition and health. The proximate composition of
chickpea and soybean is summarized in Table 1. The same amount of lipids, on a weight basis, provide
more than two-fold the energy generated by the intake of proteins and carbohydrates. In this sense, due to
its lower lipid content (up to twenty-one-fold less) compared to that of soybean, chickpea stands out as a
good option in weight management. Furthermore, the content of insoluble fiber in chickpea is comparable
or even higher than that of soybean. Due to their high contents of insoluble fiber, consumption of chickpea
and soybean may promote regular bowel movement, thus preventing constipation [34]. Individuals that
consume higher contents of fiber may show a lower risk of developing diabetes, cardiovascular diseases,
and colorectal cancer [35–37]. However, the concept of antioxidant dietary fiber [38] has been gaining
attention as several studies support the significant contribution of insoluble-bound phenolics in fruits,
legumes, and vegetables and their processing by-products [39–44]. Therefore, the transport of dietary
antioxidants through the gastrointestinal system was highlighted as an essential function of insoluble
fibers [45]. In addition, protein concentrates are potential sources of healthy isoflavones [46]. Although some
individuals may be allergenic to chickpea proteins, this feedstock is not consumed as a raw material.
Gupta et al. [47] have summarized some industrial and home processed chickpeas and their potential to
prevent adverse health effects caused by the presence of allergic components.
Table 1. Proximate composition (g/100 g) of chickpea and soybean.
Component Chickpea Soybean References
Ash 2.54–3.90 4.42–6.29 [48–52]
Lipid 1.12–6.80 14.9–23.3 [48–54]
Protein 18.3–25.2 36.3–47.0 [48–54]
Soluble fiber 1.23–1.38 9.05–9.33 [50,52]
Insoluble fiber 14.1–23.2 18.2–21.2 [50,52]
According to Valdez and Bolling [55], inappropriate activation and expression of nuclear factor-κB
(NF-κB) p65 protein, which leads to inflammation, has been found to be positively correlated with the
severity of inflammation and neutrophil inflammation in biopsies from inflammatory bowel disease
patients. In addition, a recent study [56] has demonstrated that phenolic extracts containing phenolic
acids and flavonoids were able to decrease the activation of NF-κB. The literature provides sufficient
evidence on the link between oxidative stress and NF-κB activation [57,58]. Accordingly, it has been
proposed that screening the antioxidant potential of plant food phenolics could be considered a first step
in the studies aiming to prospect novel food bioactive, functional ingredients, and/or nutraceuticals [56].
Besides scavenging ROS, an “ideal antioxidant” should not only be a good reducing agent but must exhibit
chelating capacity, and some isoflavones fit these characteristics. Therefore, as for the antioxidant potential,
this review focuses on isoflavonoids from chickpea and soybean, the latter being the reference feedstock.
When appropriate, the remaining phenolic compounds are cited to support a discussion on the role of
structure/activity. The health benefits are discussed in terms of the prevention of cardiovascular diseases
(CVD), certain types of cancer, diabetes, and obesity, among others, as inflammation and oxidative stress
are common to all of them. In short, this contribution may guide the industry in manufacturing functional
foods and/or ingredients by using chickpea which, thus far, is an undervalued feedstock.
2. Genetics
Although the benefits of phenolic compounds (e.g., phenolic acids and flavonoids), in food, feed,
cosmetics, and medicine are well known, the genetic basis regulating their content in edible seeds is still
not fully understood [59–63]. Isoflavones are the main compounds contributing to the phenolic profile
of soybeans (2n = 40 chromosomes) [64]. Unraveling the genetics underlying their accumulation in
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seeds has been difficult because of several factors. Soybean has many quantitative trait loci (QTL) with
small individual effects involved in an additive fashion that affects the phenotype and, by consequence,
the accumulation of secondary metabolites [65–67]. Cai et al. [60] found that qIF5-1 can explain 49–52% of
the isoflavone accumulation in Huachun 2 ×Wayao F7:8–10 recombinant inbred lines, still far from being
an easy trait to be determined and in line with other authors [59] who list several small-effect impact of
QTLs on isoflavone seed content. However, in this intricate network, Li et al. [68] found four multidrug
and toxic compound extrusion (MATE) transporter-encoding genes in wild soybean that increased
antioxidant content and are unrelated to the phenylpropanoid pathway, which indicates phenolic
intercellular transportation processes with a potential to be determinant. Besides, soybean possesses a
complex genome that has passed by several whole genome duplication events [69,70]. Another concern
stems from the fact that isoflavone content is strongly modulated by environmental conditions
during seed development, thus affecting their synthesis and accumulation [69,71]. The variation
of a warmer to a normal year in a two-year trial planted in eastern Maryland reduced isoflavones
by c.a. 50% due to the higher temperature, while a cooler central location on the same state was
not affected [72]. Individual identification and quantification of 12 different isoflavones of soybean
seeds (including the most cited glycitein, daidzein, and genistein) have been technically difficult,
cumbersome, and expensive, with liquid chromatography coupled to spectrophotometric detection
being the most commonly used technique [60,73]. In order to properly determine the underlying genetic
nuances of isoflavone accumulation, it is pivotal to have the most common compounds consistently
determined and preferably in a high throughput setup. In addition, epistatic interactions, that is,
the particular combination of alleles that results in a change in the phenotype, meaning that the same
allele can produce different phenotypes in a different genetic background, are responsible for a great
proportion of the observed phenotypic variance [74,75]. Furthermore, adding complexity to QTL
analysis for validating isoflavone accumulation involves multiple interactions between those QTLs with
different environmental variables that affect this trait [76,77]. The literature shows contrasting values
of the heritability, that is, the proportion of observed phenotypic variability among individuals that is
due to genetic differences among them, for isoflavones content of soybean seeds. These heritability
values range between lower than 40% [66,67,78] and higher than 80% [79,80]. Thus, in the latter case,
indicating that most of the variation among genotypes is explained by genetic effects allows to fine
map major QTLs associated with both individual and total isoflavone content in soybean seeds, that
could potentially be introgressed into elite cultivars through marker-assisted selection (MAS) [81].
The first study of DNA markers related to isoflavone content of soybean seeds used the recombinant
inbred line (RIL) population ‘Essex’ × ‘Forrest’, and the markers associated to this trait was reported
by Njiti et al. [82]. Using the same RIL population, subsequent works identified new QTLs associated
with genistein, glycitein, and daidzein on six different soybean chromosomes [65,78,83]. Another RIL
population ‘AC756’ × ‘RCAT Angora’ was employed for the identification of QTLs associated with
genistein, glycitein, and daidzein [66]. In parallel, the same major QTL (on chromosome 7) was detected
in another population based on the parental lines ‘Zhongdou 27’ × ‘Jiunong 20’ [67]. Other two
major QTLs associated to total isoflavone content, genistein, glycitein, and daidzein were reported on
chromosomes 5 (QDZGT1) and 8 (QDZGT2), by utilizing the ‘Hwangkeum’ (Glycine max) × ‘ITI82932’
(Glycine soja) population [84]. Other groups developed additional RILs populations (‘Essex’ × ‘PI
437654’, ‘Magellan’ × ‘PI 437654’) with the objective to identify major isoflavone-associated QTLs,
and coincided with the previous reported QTLs, although several isoflavones-associated QTLs were
detected in these studies [59,75,76]. This research group identified five QTLs that contributed to the
concentration of isoflavones, possessing single or multiple additive effects on isoflavone component
traits, and a major locus on chromosome 5 (Gm05) was validated that alone accounted for up to 10% of
the phenotypic variance for glycitein, and 35–37% for daidzein, genistein, and the sum of all three
soybean isoflavones. This Gm05 QTL was consistently associated with isoflavones concentration
across different crosses, locations, and years [76]. More recently, a high-density soybean genetic
map was constructed using RILs (Luheidou2 × Nanhuizao, F5:8), and 41 QTLs were identified that
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contributed to the isoflavone content, standing out one novel major QTL on chromosome 20, qIF20-2,
which contributed to a majority of isoflavone components across various environments and explained
a high amount of phenotypic variance (up to 35.3%) [85]. Using specific-locus amplified fragment
sequencing in the F5:7 of the same RIL cross, Pei et al. [86] found four new QTLs (qG8, qMD19,
qMG18, and qTIF19) associated to genistin, malonyldaidzin, malonylgenistin, and total isoflavones,
respectively. Meanwhile, another study identified 44 isoflavone-associated QLTs using soybean
landraces and restriction site-associated DNA tag sequencing (RAD-seq), including 55 candidate genes
on 16 chromosomes, explaining 72.2% of the total phenotypic variation, reflecting the complex genetic
nature of the synthesis and accumulation of isoflavones on soybean seeds [87]. Subsequently, 15 stable
QTLs associated to individual and total isoflavone content were identified using a high-density soybean
genetic map across multiple environments of China, by utilizing a population of 196 F7:8–10 RILs
(Huachun 2 ×Wayao). In this study, one major QTL on chromosome 5, qIF5-1, contributed significantly
to the total isoflavone content and explained between 43.3 and 52.5% of the total isoflavone content
phenotypic variance [60]. Taking all together, the research results of the last 20 years have generated
knowledge for a better understanding of the genetics of isoflavone accumulation in soybean seeds,
especially with the fact that there are genetic regions on chromosome 5 that appear to play an important
role in the regulation of this trait. In addition, there is scope available for improvement of isoflavone
content through MAS [88], which could be a powerful tool to increase isoflavone content by the
introgression of valuable QTLs/genes/alleles (i.e., identified on chromosome 5) into elite cultivars of
soybean that would certainly augment their seed quality. Another promising way of finding candidate
genes that could further be validated by QTL is the use of genome-wide association studies (GWAS).
Recently, an MYB transcription factor was found to regulate isoflavone contents in soybean hairy roots,
the GmMYB29 activated the promoters IFS2 and CHS8, while its overexpression or silencing by RNAi
had positive and negative effects on isoflavone content [89]. Nonetheless, further studies to verify and
confirm biosynthetic pathways using RNA-sequencing and co-expression network analysis can lead to
the identification of specialized varieties, for example, producing coumestrol [90].
Contrary to soybean, there is very little information in the literature on the role of genetics with
respect to the polyphenolic composition of chickpea (2n = 16 chromosomes) [91], and to the best of our
knowledge, there is no study associated with the genetic regulation of isoflavones on chickpea seeds.
One important field of research in the last decades has been the alteration of isoflavone contents and
composition upon germination [92]. However, the available literature demonstrates that variations in
the isoflavone contents and profile are dependent on the process [93,94]. Changes of the isoflavones
content upon germination has very likely a genetic regulation explanation, although no QTLs/genes
associated with this phenomenon have been reported so far. Most of the genetic studies of chickpea
have focused on the identification of genetic regions using different methodologies associated to
improving agronomic traits, such as increasing seed yield and the yield of components [95–103].
In addition, a genetic approach has been used to develop drought/heat tolerance [70,104–108], as well
as disease resistance, for example, Ascochyta blight [109,110]. Solid and broad genetic studies on
chickpeas are emerging and paving the way for breeding approaches targeting phenolic compounds
in general [111–113]. From a nutritional and functional food perspective, genetic studies have been
carried out on chickpeas to identify genetic regions associated to seed color [114–116], seed protein
content [117], and seed-zinc/iron concentrations [118]. Based on the existing literature, it seems
clear that increasing the levels of isoflavones on chickpea seeds by germination could have valuable
implications, to gain insight into the genetic basis regulating this process, which would be of scientific
interest to identify QTLs/genes/alleles of relevance that could be transferred into elite chickpea cultivars
through MAS and/or traditional breeding. In addition, genetic comparative studies between soybeans
and chickpeas are of importance to understand whether the existing knowledge of the genetics
underlying the regulation of isoflavone synthesis in soybeans might be transferable to chickpea.
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3. Main Phenolic Bioactives and Their Quantities
In addition to being rich sources of carbohydrates, protein, fibers, minerals, and vitamins, chickpea,
soybean, and other legumes also contain bioactive substances [119–123]. Phenolic compounds are
present in both soluble and insoluble-bound forms. Therefore, one should bear in mind that optimizing
the extraction of phenolics in the soluble form is desirable (Table 2).
Table 2. Total phenolic contents (mg GAE/g) of chickpea and soybeans.
Feedstock Organic Solvent * References
Acetone Ethanol Methanol
Chickpea 1.44–1.81 0.93–1.54 8.02–10.84 [124–128]
Soybean 0.98–2.62 2.04–6.10 2.10–2.31 [121,129–132]
* Only the organic solvent is mentioned. The concentration in water varies among different studies.
Xu and Chang [121] carried out a comparative study on the yield of phenolics of legumes as
affected by the extraction solvent. Their results support the use of 50% acetone from chickpea and
yellow soybean while black soybean showed a higher total phenolic content (TPC) when acidic 70%
acetone (0.5% acetic acid) was employed. The contrast found by these authors might be related to
differences in specific phenolics present. Supporting this assumption, it is worth to highlight the study
carried out by Yoshiara et al. [120]. These researchers used a centroid design and made a valuable
contribution by demonstrating that glycosidic isoflavones were better extracted with the polar ternary
mixture (water, acetone, and acetonitrile, 2:1:1, v/v/v) while malonyl-glycosidic isoflavones showed
higher extraction yields with mixtures of water, acetone, and ethanol (2:1:1, v/v/v). Finally, water and
acetone (1:1, v/v) rendered a higher extraction of isoflavones as aglycones. Examples for the total
phenolic contents (TPC) of soybean and chickpea are summarized in Table 2, while the isoflavone
profile of chickpea and soybean is summarized in Table 3.
Chickpea and soybean have significant amounts of flavonoids, especially isoflavones. According to
the literature, the total isoflavone content (TIC) varied from 153 to 340 mg/100 g of chickpea and from
165 to 336 mg/100 g of soybean [51,126]. In chickpea, the major isoflavones found were biochanin A and
formononetin while smaller amounts of genistein and daidzein might also occur [94]. Considering the
contribution of each isoflavone to TIC, the isoflavone profile of chickpea and soybean is summarized
in Table 3. Formononetin and biochanin A, which are present in chickpeas, have not been reported in
soybeans. In addition, the presence of phenolic acids and other flavonoids in chickpeas were reported
by Thavarajah and Thavarajah [133]. However, isoflavonoids have been reported as the main bioactive
phenolics of chickpea [93]. As for the absolute concentration, biochanin A (180 µg/g) and its derivatives,
biochanin glucoside (80 µg/g), and biochanin A glucoside malonylated (60 µg/g) made the highest
contribution to the isoflavone profile of chickpeas, while formononetin (100 µg/g) rendered a lower
contribution [93]. The same study [93] also reported the concentration of daidzein (120 µg/g) and
genistein (60 µg/g). It is important to highlight that these concentrations were in good agreement with
those found in soybeans, which were in the range of 18.5–242.7 µg/g for daidzein and 13.0–158 µg/g for
genistein, which suggests that chickpeas may be considered a good substitute for soybeans as a source
of isoflavone aglycones [132]. Finally, it is noteworthy that current identification and quantification of
isoflavones in these feedstocks were mainly carried out using hyphenated techniques, such as liquid
chromatography coupled to tandem mass spectrometry (LC–MSn), thus increasing the reliability of
the results.
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Table 3. Isoflavone profile (%) of chickpea and soybean *.
Compound Chickpea Soybean Method Reference
Formononetin 2.61–16.6 nd UPLC-ESI-Q-TOF-MS, HPLC/MS [94,134]
Biochanin A 17.8–30.0 nd UPLC-ESI-Q-TOF-MS, HPLC-ESI/MS [94,135]
Biochanin glucoside 13.3–29.1 nd UPLC-ESI-Q-TOF-MS [94]
Daidzein 0.30–20.0 0.32–7.65 HPLC, UPLC-ESI-Q-TOF-MS, UPLC-ESI-Q-TOF-MS [94,130,132,134]
Daidzin nd 8.73–21.3 UPLC-ESI-Q-TOF-MS [130,132]
Malonyldaidzin nd 20.5–28.1 HPLC, UPLC-ESI-Q-TOF-MS, UPLC-ESI-Q-TOF-MS [130,132]
Genistein 10.0–25.5 0.26–1.00 HPLC, UPLC-ESI-Q-TOF-MS, UPLC-ESI-Q-TOF-MS,HPLC-ESI/MS [94,130,132,135]
Genistin nd 7.73–23.8 HPLC, UPLC-ESI-Q-TOF-MS [130,132]
Malonylgenistin nd 36.0–42.5 HPLC, UPLC-ESI-Q-TOF-MS [130,132,136]
Glycitein nd 0.78–0.97 UPLC-ESI-Q-TOF-MS [132,135]
Glycitin nd 3.14–4.51 HPLC, UPLC-ESI-Q-TOF-MS [130,132]
Malonylglycitin nd 1.93–7.98 HPLC; UPLC-ESI-Q-TOF-MS [130,132]
Abbreviations: HPLC, high-performance liquid chromatography; UPLC, ultra-performance liquid chromatography;
ESI, electrospray ionization; Q, quadrupole; TOF, time of flight. * MS (mass spectrometry) may contemplate tandem
mass spectrometry (MSn).
4. Potential Health Benefits
4.1. Antioxidant Potential
Dietary phytochemicals, specifically phenolic compounds, are known by their potency in
scavenging ROS. Likewise, the antioxidant activity of phenolic compounds may be explained by their
reducing power and/or metal-chelating activity towards ferric and ferrous ions, respectively. The Fenton
reaction, also known as the Haber-Weiss cycle, is an important biological model. Peroxyl and hydroxyl
radicals may be pointed among the most important ROS as both participate in the Fenton reaction.
The role of ferric and ferrous ions in the Fenton reaction has also been addressed [23]. Peroxyl radicals
show a longer half-life compared to that of hydroxyl radicals. Consequently, while hydroxyl radicals
may damage intracellular components, the deleterious effects of peroxyl radicals may be extended to
biological fluids [137,138].
The antioxidant properties of soybean are mainly associated with the presence and/or
profile of isoflavones. Furthermore, a highly positive correlation existed between the
concentration of genistein in phenolic extracts of soybean and their ability in scavenging
2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) diammonium salt (ABTS) radical cation [130].
The presence of genistein as aglycone has been found in only one sample (out of seven) in Egyptian
cultivars of chickpeas as evaluated by RP-HPLC-DAD-ESI-QTOF-MS (RP: reversed-phase; DAD: diode
array detection; ESI: electrospray ionization; QTOF: quadrupole time of flight; MS: mass spectrometry),
while its conjugated counterpart was detected in all samples [139]. The experience of our group with
various feedstocks has demonstrated that the chelating ability of polyphenols is not simple to be
confirmed, which is the opposite of the reducing power as, in general, the latter has been correlated
with TPC [137,138].
As for the structure/activity, phytochemicals with one or more methoxy substitutions are regarded
as potent chelating agents [140]. In contrast, compounds lacking catechol or galloyl moiety do not show
any complex formation [141]. The properties of genistein and biochanin A as metal chelators have been
confirmed by elemental analysis, Fourier-transform infrared spectroscopy, thermogravimetric analysis,
and electrospray ionization mass spectrometry [142]. However, daidzein does not chelate Cu(II) or
Fe(III), thus supporting a structure/activity relationship. These authors [142] also suggested that
isoflavones bind metals at the 4-keto and the 5-OH sites. Additionally, it has been hypothesized that the
ratio of ferric to ferrous ion is important for rapid initiation of lipid peroxidation through the Fenton
reaction and the ratios of 1:1 to 7:1 (Fe3+/Fe2+) are optimum [143]. Therefore, reducing the concentration
of ferric ions in the system could be beneficial. However, due to their cyclic nature, ferrous ions are
oxidized to the ferric form, and the latter is again reduced to the ferrous form. In this scenario, it has
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been suggested that an “ideal antioxidant” should not only be a good reducing agent but must exhibit
chelating capacity [23], hence genistein and biochanin A could be classified as ideal antioxidants.
Trolox, a water-soluble analog of vitamin E, is used as a standard to express the antioxidant
activity as evaluated by several methods (e.g., 2,2-diphenyl-1-(2,4,6-trinitrophenyl)hydrazyl (DPPH),
ABTS, ferric reducing antioxidant power (FRAP), oxygen radical absorbance capacity (ORAC)).
Therefore, by examining the antioxidant activity in the available literature (Table 4), especially from
the same research team and feedstock, it is easy to understand that the antioxidant activity should not
be faced as a single number but rather as an index and/or trend. Yoshiara et al. [130] evaluated the
antiradical activity of soybean seeds. The antioxidant potential towards DPPH radical and ABTS radical
cation was 289 ± 1.0 and 252 ± 6.0 µmol Trolox equivalent/g, respectively. In general, these differences
have been explained by their operative mechanisms. In fact, the ability of phenolic compounds in
scavenging free radicals stems from single electron transfer (SET) or hydrogen atom transfer (HAT).
Furthermore, the same authors [130] also showed that, regardless of the method, germination increased
the antioxidant properties of the test material.
Table 4. Scavenging of peroxyl radical and reducing power of chickpea and soybean.
Method Chickpea Soybean Reference
ORAC (µmol TE/g) 8.74–52.2 22.2–86.8 [93,121,125,128,144]
FRAP (mmol Fe2+/g) 0.73–1.13 1.24–1.96 [121,128,145]
Abbreviations: ORAC, oxygen radical absorbance capacity; FRAP, Ferric reducing antioxidant power; TE,
Trolox equivalents.
A deeper evaluation of the data reported by Yoshiara et al. [130] shows that the greatest increase (up
to 138%) was found against ABTS radical cation compared to the improvement towards DPPH radical
(up to 12%). Likewise, while a significant difference between the antioxidant activity (ABTS assay) of
free and insoluble-bound phenolics of soybean was found by Ademiluyi and Oboh [129], these authors
did not find any difference with respect to the reducing power. Therefore, these studies [129,130]
demonstrate that specific phenolics (e.g., conjugated versus isoflavones as aglycones) or fractions
(free versus insoluble-bound phenolics) respond differently to each method. Additionally, besides
the degree of glycosylation, the number and position of hydroxyl groups in polyphenols may also
influence their antioxidant potential [23,126].
Beyond the starting material, their fractions (e.g., cotyledons, epicotyls, radicles, and hypocotyls)
may show different antioxidant properties [130]. According to Sreerama et al. [119], the antioxidant
activity towards hydrogen peroxide and DPPH radical was in the decreasing order of seed coat >
embryonic axe > cotyledons. Therefore, evaluating the whole material, that is, along with non-edible
portions, may not provide the best picture of the potential antioxidant activity under physiological
conditions. Like plant foods, the human body relies on antioxidant systems to eliminate free radicals
and the excessive increase in their levels can damage proteins, lipids, and nucleic acids. In addition,
oxidative stress and lipid peroxidation are major causes of chronic ailments, such as neurodegenerative,
inflammatory, and cardiovascular diseases. Likewise, the role of ROS in allergies, immune system
dysfunctions, type 2 diabetes, obesity, certain types of cancer, and aging have been reported [146,147].
In humans, endogenous antioxidant enzymes, such as catalase (CAT), superoxide dismutase (SOD),
glutathione peroxidase (GPx), glutathione reductase (GR), and peroxiredoxins (PRXs), exert antioxidant
function during oxidative stress [148,149]. Phenolic compounds may also modulate the activity of
antioxidant enzymes. Genistein has been found to improve the activity of antioxidant enzymes, as well
as decreasing the levels of ROS and lipoperoxide in the brain and liver of C57BL/6J streptozotocin (STZ)
diabetic mice, thus reverting the overproduction of ROS and restoring glutathione content and the
reduced glutathione (GSH) and oxidized glutathione (GSSG) ratio [150]. Although these authors [150]
did not address the bioaccessibility and further bioavailability of genistein, the improved oxidative
status of brain and liver found by them suggests that the test compound was bioavailable. It is well
accepted that isoflavones as aglycones are usually more bioavailable than their conjugated counterparts.
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The bioaccessibility and bioavailability of several phenolic compounds have recently been revised and
published elsewhere [151]. Furthermore, genistein also increased the activity of hepatic superoxide
dismutase, catalase, and glutathione peroxidase of STZ-induced diabetic rats [152]. Genistein and daidzein
decreased malondialdehyde (MDA) production against anoxia-glucopenia and reperfusion damage in rat
urinary bladder (A-G/R) [153], thus supporting their antioxidant activity in vivo.
Biochanin A, which is found in chickpeas [154], has been gaining attention due to its therapeutic
value. Biochanin A reduces oxidative stress by decreasing MDA levels and by increasing the levels
of CAT, SOD, and total antioxidant status in diabetic rats [155]. Exposure to arsenic through the
consumption of contaminated drinking water and foods may cause significant negative health effects,
including cancer and non-cancerous diseases. Jalaludeen et al. [140] tested the therapeutic efficacy of
biochanin A against arsenic-induced renal and cardiac damage in rats. According to these authors,
Biochanin A alleviated oxidative stress in the kidney of arsenic-treated rats. In addition, biochanin A
exhibited a protective effect against oxidative stress in a rat model of Parkinson’s disease, inhibiting
the nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase) activation and MDA
production and increasing SOD and GPx activities in the rat brain [156].
4.2. Anti-Inflammatory Effects
During oxidative stress, interleukins and inflammatory mediators are produced. Isoflavones from
natural products have shown anti-inflammatory properties in vitro and in vivo [157]. Verdrengh et al. [158]
showed that subcutaneous treatment with genistein was able to suppress the delayed-type hypersensitivity
reaction to oxazolone and the granulocyte-mediated response. Likewise, Zhang et al. [159] demonstrated
that genistein treatment inhibited the proliferation of rheumatoid synoviocytes by reducing the matrix
metallopeptidase 9 (MMP-9) expression [159]. Genistein may also prevent periodontal disease.
Bhattarai et al. [160] tested this hypothesis in a mice model of periodontitis. According to these
authors, genistein was able to protect against alveolar bone loss and periodontal tissue degradation.
Neuroinflammation, a phenomenon that is primarily mediated by microglial cells, may culminate in
Parkinson and Alzheimer disease, multiple sclerosis, amyotrophic lateral sclerosis, among other chronic
ailments. The potential of genistein in treating and/or preventing neuroinflammation has already been
discussed [161]. The modulatory effects induced by flavonoids are mediated by their impact, mainly,
on mitogen-activated protein kinase (MAPKs) and nuclear factor-kappa B (NF-κB) [161]. Lending support
to the statements of Spagnuolo et al. [161], Ji et al. [162] demonstrated that tumor necrosis factor alpha
(TNF-α) and interleukin 6 (IL-6) release in lipopolysaccharide (LPS)-stimulated macrophages was inhibited
upon genistein treatment via NF-κB, specifically by stimulating adenosine monophosphate-activated
protein kinase (AMPK). It has been reported that in vitro LPS-stimulated microglia cells (BV2) liberate
less nitric oxide, prostaglandin E2, IL-1β, and TNF-α after genistein treatment [163]. In this scenario,
the authors also attributed the inhibitory effects of genistein on the NF-κB. Furthermore, genistein reduced
the binding of the LPS to the toll-like receptor 4 (TLR-4) receptor on microglial cells [163].
Biochanin A, a derivative of genistein, is also able to reduce neuronal inflammatory damage of
the articular cartilage [164,165]. Wu et al. [166] showed that biochanin A attenuated LPS-induced
pro-inflammatory responses and inhibited the activation of the MAPK pathway in BV2 microglial cells
and decreased the expression of TNF-α and interleukin 1 beta (IL-1β). Therefore, the mechanisms of
action of biochanin A are attributed to its ability in reducing phosphorylation of MAPK, c-Jun N-terminal
kinases (JNK), extracellular signal-regulated kinase (ERK), and p38 [166]. However, biochanin
A acts simultaneously on other targets. Ming et al. [167] reported that biochanin A suppressed
the rolling and adhesion molecules expression, specifically the vascular cell adhesion molecule
1 (VCAM-1), intercellular adhesion molecule 1 (ICAM-1), and E-selectin molecules on human
umbilical vein endothelial cells. The effects of biochanin A are related to the activation of Peroxisome
proliferator-activated receptor (PPAR)-γ. Furthermore, its ability to reduce NF-κB activation has also
been reported [167]. E-Selectin reduction is a marker for endothelial function improvement, controlled
metabolic condition, and arteriosclerosis and inflammation reduction in diabetic patients [168,169].
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Daidzein, another isoflavone aglycone, also shows anti-inflammatory potential [170]. According to
Ahmad et al. [171], daidzein reduced the evolution of rheumatoid arthritis in Wistar albino rats.
These authors showed that the levels of TNF-α and rheumatoid arthritis scores were improved when
compared to the control group. Furthermore, the same study suggested protective effects towards
CVD as it reduced the levels of low-density lipoproteins and triacylglycerols. Beneficial effects of
daidzein in the lung were also observed in mice. Feng et al. [172] used an LPS-induced acute lung
injury model. The test material reduced important inflammatory parameters, that is, the number of
infiltrated cells and levels of inflammatory cytokines in bronchoalveolar lavage fluids. The inhibition of
TLR4-MyD88-NF-κB signaling pathway is possibly involved in the protective action of daidzein. NF-κB
and signal transducer and activator of transcription 1 (STAT-1) routes are important targets related to
nitric oxide production, an important inflammatory mediator [173]. Besides reducing the NF-κB route,
other authors have also shown that daidzein and other flavonoids (e.g., kaempferol and quercetin)
are able to simultaneously affect the STAT-1 route [173]. Penga et al. [174] attempted to improve the
pharmacokinetic properties of daidzein. These authors synthesized new sulfonic acid ester derivatives
with much better pharmacologic effects than the original molecule. Furthermore, the derivatives
inhibited phosphorylation of JNK and showed significantly enhanced anti-inflammatory activities by
two to four orders of magnitudes over that of the parent daidzein in TNF-α-stimulated Caco-2 cells.
Formononetin, a daidzein derivative, has in vivo antinociceptive effects in mice models and
reduced the neutrophil migration to the peritoneal cavity and hind paw edema [175]. Formononetin was
also evaluated using an LPS-stimulated lung injury model on mice and showed promising protective
effects. Ma et al. [176] showed that formononetin treatment reduced the bronchoalveolar lavage fluid
cell numbers, increased PPAR-γ gene expression, and improved the superoxidase dismutase activity
while simultaneously inhibited the myeloperoxidase activity. Wu et al. [177] evaluated the effects of
formononetin on dextran sulfate sodium- (DSS-) induced acute colitis model in mice. Dose-dependent
attenuation of colitis was noted, and, according to these authors, the effects of formononetin may stem
from the inhibition of NLRP3 inflammasome signaling pathway.
4.3. Polyphenols in the Prevention of CVD
A recent report stated that CVD is the most common non-communicable ailment, claiming
one-third of total global death [178]. In general, low-density lipoprotein-cholesterol (LDL-c) levels
are predictors of death from cardiovascular diseases (CVD) [179]. Development of atheromatous
Aplaques stems from the uptake of oxidized LDL-c, via scavenger receptors, thus leading to cholesterol
accumulation and foam cell formation [23]. Therefore, it is important to highlight that oxidized LDL-c is
the actual entity involved in the early event of atherosclerosis. Tarantino et al. [180] carried out a study
with obese patients and showed that altered copper bioavailability is a predictor of early atherosclerosis,
the main CVD risk in obese patients with hepatic steatosis. Accordingly, cupric ion-induced human
LDL-c peroxidation in vitro has been employed to anticipate the potential benefits of polyphenols in
reducing the risk of CVD, although some authors have used 2,2′-azobis (2-methylpropionamidine)
dihydrochloride (AAPH) to induce the oxidation process [181].
The generation of conjugated dienes and trienes, as well as malondialdehyde-thiobarbituric
acid (MDA-TBA) or TBA reactive substances (TBARS), have been used to monitor the level of LDL-c
oxidation [181,182]. Genistein (200 µmol/L) has shown inhibitory activity by protecting LDL-c from
peroxyl radical (azo-initiated)-induced oxidation in vitro [183]. Kerry and Abbey [183] supported their
results in the lower time required (3 h) for MDA formation compared to that of the control (7 h) as well
as evidenced by a decrease in relative electrophoretic mobility (REM) of LDL-c.
Xu et al. [184] carried out a comparative evaluation on the ability of common food legumes,
including soybeans and chickpea, towards copper-induced human LDL-c oxidation in vitro.
Total phenolics and total flavonoids were correlated (r = 0.79 to 0.94, p < 0.001) with the antioxidant
activity in this model system, and the authors suggested that phenolic compounds played a possible
role in the overall antioxidant activity of legumes. In addition, high correlations existed between
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ORAC assay (scavenging of peroxyl radical) and the protection of LDL-c against oxidation (r = 0.81 to
0.83, p < 0.001).
The potential of dietary chickpeas in reversing dyslipidemia in rats induced by a chronic high-fat
diet was studied by Yang et al. [185]. Chickpea supplementation (10% w/w) induced a favorable lipid
profile by decreasing the levels of triacylglycerols, LDL-c, and LDL-c:HDL-c ratio. Pittaway et al. [186]
suggested that dietary supplementation with chickpeas results in lowering total serum and LDL-c levels
in hypercholesterolemic women and men as compared to a wheat-supplemented diet. Improvements in
serum lipid profile (e.g., lower serum total cholesterol and LDL-c) were confirmed in another study
from the same research team [187]. These authors [185–187] did not evaluate the phenolic profile of their
starting material. However, the role of phenolics in cardiovascular diseases is well substantiated [188].
Supporting the role of legumes in the prevention of CVD, Sedaghat et al. [189] carried out a clinical trial
and demonstrated that soybean consumption decreased the level of total serum cholesterol and LDL-c
in patients with type 2 diabetes. Other clinical trials [190,191] showed similar results with respect to
the role of soybean, their products and related phytochemicals in reducing total cholesterol and LDL-c
levels, thereby improving the cardiovascular risk profile.
According to the literature [192], cellular cholesterol synthesis was inhibited by genistein (41%)
and daidzein (18%), and the effect was associated with increases in 3-hydroxy-3-methylglutaryl-CoA
reductase mRNA. After univariate analysis, Pittaway et al. [187] concluded that dietary fiber exerted
the greatest single effect by reducing serum total cholesterol, but increasing pieces of evidence show
that dietary fibers act as carriers of phenolic antioxidants [45]. Lipopolysaccharides (LPS) are present
in the cell wall of Gram-negative bacteria. Intestinal barrier dysfunction due to high intake of saturated
fatty acids facilitates LPS migration into the bloodstream, thus enabling systemic inflammation, which
is common to cardiovascular disease. Furthermore, phenolic acids and flavonoids from legume crops
show antimicrobial activity and protect barrier integrity [193,194]. Therefore, phenolic compounds
may be helpful in the prevention of CVD by inhibiting the growth of Gram-negative bacteria,
protecting barrier integrity [193,194], and possible LPS release into the bloodstream, in addition to
their well-documented anti-inflammatory action [157].
4.4. Polyphenols as Adjuvants in Cancer Prevention and Treatment
An unhealthy diet is among the risk factors responsible for cancer, a leading cause of death
worldwide. Colorectal, female breast, liver, lung, and stomach cancer are among the most common
causes of cancer death [195]. Lung cancer is most common in men, while breast cancer is most
prevalent in women. Different from other chronic ailments (e.g., obesity and diabetes), clinical trials
which are reporting the effects of soybean, chickpea, and other legumes in cancer development and/or
management are not available. However, a meta-analysis of epidemiologic studies supports the
negative correlation between soybean intake and lung [196] as well as breast cancer [197].
Girón-Calle [198] investigated the cell growth-regulating properties of chickpea seed extracts as
possible responsible anti-cancer factors. Their results demonstrated that chickpea extracts inhibited the
growth of Caco-2 cells exhibiting a cancerous phenotype. The effects of biochanin A on cell growth in
the mammary carcinoma cell line MCF-7 has also been reported [199]. The preventive action of phenolic
compounds against lung, liver, and female breast cancer is dependent on the bioaccessibility of the
compounds as these must reach the plasma and different tissues. In contrast, stomach and colorectal
cancer, which are also major causes of cancer death, do not necessarily stem from the bioaccessibility of
polyphenols. Insoluble-bound phenolics have been found in soybean and other legume seeds [200].
Insoluble-bound phenolics are not readily bioaccessible. However, it has been hypothesized that upon
human colonic microbiota fermentation, insoluble-bound bioactive phenolics can be released in the
colon [200], thus potentially preventing colorectal cancer.
DNA-damage signaling/repair are crucial pathways to the etiology of human cancers [201]. In fact,
it has been well accepted that DNA strand breakage may culminate in mutagenesis and affect replication
and transcription of DNA, which are pointed among the causes of cancer initiation [23]. The presence of
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phenolic extracts from different legume seeds inhibits peroxyl radical-induced DNA damage [202,203].
Soluble and insoluble-bound fractions of black soybean seed coat and cotyledon contain isoflavones
as aglycones, as well as their conjugated forms [204]. Phenolics from back soybean seed coat showed
antioxidant activity by preventing AAPH-induced oxidative DNA-damage in HepG2 cells as noted by the
inhibition of formation of 8-hydroxy-2′-deoxyguanosine (8-OHdG) as a biomarker for oxidative stress [203].
Mycotoxins, as chemical carcinogens, induce DNA-damage in cell models as well as in vivo [205,206].
The occurrence of aflatoxins, deoxynivalenol, and zearalenone has been reported in soybeans [207,208], while
chickpea and chickpea-based products tested positive for aflatoxin and ochratoxin A [209]. However, several
studies [210–215] have demonstrated that phenolic compounds protected against mycotoxin-induced
dysfunctions (e.g., aflatoxins, deoxynivalenol, and zearalenone) in animal and cell models. Therefore, as a
source of phenolic compounds, soybeans, chickpea, and their processing by-products may counteract
potential health concerns caused by mycotoxins.
The role of transcription factors, such as NF-κB, AP-1, and STAT3 and their gene (e.g., tumor necrosis
factor, interleukin-1, interleukin-6, chemokines, cyclooxygenase-2, 5 lipoxygenase, matrix metalloproteases,
and vascular endothelial growth factor, adhesion molecules, and others), in inflammation and cancer
has been well discussed in the available literature [216]. Acrylamide is probably carcinogenic to humans.
Accordingly, chickpea flour has been used as a strategy to decrease the formation of acrylamide in
processed foods (e.g., baked goods and fried potato) [217]. Some authors [217,218] have suggested that
the beneficial effects of protein hydrolyzates stem from the ability of chickpea and soybean peptides in
reacting with acrylamide, thus forming new derivatives. However, another study [219] has supported the
ability of flavonoids (e.g., daidzin, genistin, daidzein, and genistein) in reducing acrylamide formation,
which was correlated to the number of phenolic hydroxyl groups of flavonoids, their antiradical activity,
and reducing power.
Surgery, chemotherapy, radiation, or their combination are the most common treatments for
cancer [195]. Furthermore, the oxidative stress-based hypothesis involving the production of ROS
due to the use of anticancer drugs has gained acceptance [220]. Side effects of chemotherapy include
cardiotoxicity, hepatotoxicity, nephrotoxicity, neurotoxicity, and gastrointestinal and pulmonary
toxicity [221]. In addition, hepatotoxicity and cardiotoxicity may be linked to drug-induced oxidative
stress [220,222]. Anthracycline (ANT), which has been used in the treatment of leukemias, breast,
and lung cancer, go through redox cycling where ROS are generated [220] due to the presence of
ANT-Fe2+ complexes. The lower oxidative stress in anthracycline-treated rats, compared to control,
was attributed to treatment with phenolic compounds [222].
The antioxidant activity and radioprotection isoflavone against gamma-irradiation were investigated
by Dixit et al. [223]. These authors concluded that soy isoflavone scavenged free radicals induced by
gamma-irradiation exposure and inhibited radiation-induced cellular damages. They also found increased
survival rate of the animals pretreated with soy isoflavone and improved hematological and histological
parameters as compared to the irradiated control group. Singh et al. [224] evaluated the effect of X-ray
irradiation exposure on human lymphocytes isolated from the peripheral blood in vitro and suggested an
age-related decline in DNA repair competence. The potential of genistein in preventing DNA damage,
chromosomal aberration, and apoptosis triggered by X-ray irradiation in HL-7702 (L-02) cells was studied
by Song et al. [225]. According to them, the molecular mechanism underlying its radioprotective properties
might be explained by the inhibition of the endoplasmic reticulum stress marker GRP78, the promotion of
the expression of HERP, a multifunctional protein, and the up-regulated expression of HUS1 and hHR23A,
which are DNA repair-related genes. Therefore, consumption of soybeans and chickpea as natural sources
of antioxidants may play an adjuvant’s role in cancer treatment.
4.5. Polyphenols in the Management and/or Treatment of Type 2 Diabetes and Obesity
Overweight (BMI [body mass index] 25–29.9) and obesity (BMI > 30) are defined by the World
Health Organization (WHO) as abnormal or excessive fat accumulation that may impair health.
Their fundamental cause is an imbalance between energy intake and energy expenditure, and their
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prevalence is on the rise around the world. From the 7500 million world population, it is estimated that
774 million are obese, and more than 50% of them live in the USA, China, or India [226]. Type II diabetes
mellitus, which represents at least 90% of all diagnosed cases of diabetes, is one of the major diseases
commonly associated with obesity. Diabetes is the fourth or fifth cause of death in the developed
world, and together with obesity, they are projected to rise if measures are not taken to diminish this
escalation [227]. Several strategies have been used to control and reduce these two diseases, among
them dietary interventions, increased physical activity, medication, and consumption of functional
foods and/or nutraceuticals are important. However, employing a combination of several strategies
is probably more effective. Soybeans and chickpeas contain several kinds of bioactive compounds
that may have positive effects on the control of obesity and type II diabetes. Thus, it is important to
describe and discuss the main findings in this research area.
4.5.1. Digestive Enzymes as Biochemical Targets of Bioactive Compounds
Food macronutrients (carbohydrates, lipids, and proteins) must be hydrolyzed, and their
hydrolysis products are absorbed through the digestive tract before they can be used as a source of
energy and biosynthetic precursors in the tissues of higher animals. Many secondary metabolites
present in soybeans, chickpeas, and other pulses are potent inhibitors of the enzymes responsible
for the hydrolysis of food macronutrients. Protease inhibitors are especially abundant and may be
considered as antinutritional factors because they reduce protein digestibility and hence, diet quality.
They can have a negative health impact, especially in monogastric animals and in protein-restricted
diets, but their effects can usually be eliminated or, at least, reduced by cooking, since many protease
inhibitors are themselves proteins or peptides [228,229]. Other antinutritional factors, such as phytic
acid, reduce mineral bioavailability by forming insoluble complexes with metal ions.
Likewise, inhibitors of the enzymes responsible for dietary carbohydrate and lipid hydrolysis
used to be considered as antinutritional factors as they could reduce the bioavailability of these high
energy nutrients enough to cause growth inhibition [228]. However, in recent times, the capacity of
secondary metabolites in inhibiting carbohydrate and lipid hydrolysis has been viewed as a beneficial
property. In fact, reducing the absorption of these macronutrients has been pointed out as one of the
mechanisms by which some bioactive compounds decrease the risk of developing obesity and type II
diabetes. Phenolic compounds are among the secondary metabolites that, in addition to their many
biological activities, are being recognized as inhibitors of digestive enzymes. They can inhibit protein,
carbohydrate, and lipid hydrolysis to different degrees, depending on several factors, including the
structure of the enzyme as well as the phenolic compounds [230–232].
Starch (composed of two distinct polysaccharides, amylose and amylopectin) is the most abundant
dietary carbohydrate. It is broken-down to monosaccharides (glucose) through the action of two
types of enzymes present in the human digestive tract: α-amylases and α-glucosidases. There are two
isoforms of human α-amylase: salivary and pancreatic. They both hydrolyze internal α1→4 glycosidic
linkages of starch, yielding short-chain oligosaccharides. Pancreatic α-amylase, which is secreted by
the pancreas but acts in the small intestine, carries out most of the starch hydrolysis (70 %) and its
final products are mainly maltose, maltotriose, and dextrins (fragments of amylopectin containing
α1→6 branched units). Human pancreatic α-amylase, a 55 kDa enzyme, contains 496 amino acid
residues organized in three structural domains (A, B, and C). Domain A contains the catalytic triad
(Asp197, Glu223, and Asp300) inside a (β/α)8 barrel [231].
Intestinal α-glucosidases act upon the products of pancreatic α-amylase, producing free glucose
that is absorbed through specific transporters in the membrane of enterocytes. They consist of four
different individual enzymes organized in two complexes: maltase-glucoamylase (MGAM) and
sucrase-isomaltase (SI). Each complex possesses a molecular weight of approximately 260 kDa and
contains a C-terminal (Ct) luminal domain and an N-terminal (Nt) domain covalently linked with a
transmembrane protein of the intestinal brush border. Each domain has a distinct catalytic activity:
MGAM Ct domain is glucoamylase and Nt domain is maltase, SI Ct domain is sucrase and Nt
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domain is isomaltase [233]. All four enzymes exhibit exo hydrolytic activity towards the non-reducing
ends of α1→4 glycosidic linkages, but each catalytic unit possesses unique enzymatic characteristics.
For example, glucoamylase (MGAM Ct) has the highest α1→4 hydrolytic activity, while isomaltase (SI
Nt) can also hydrolyze α1→6 bonds [234]. α-Glucosidases from different origins, including those from
rat and mouse intestine as well as yeast and bacterial α-glucosidases, have been used in studies aiming
to screen potential α-glucosidase inhibitors [235]. Therefore, comparison among them may be difficult.
Fatty acids, which are the major lipid fuels of animal cells, are released from dietary triacylglycerols
(found in fats and oils) by the action of intestinal lipases and then diffuse into the enterocytes crossing
their apical membrane and are used as energy sources in many tissues. Although two pre-duodenal
lipases are present in the human digestive system (lingual and gastric lipases), pancreatic lipase
(secreted by the pancreas but acting in the small intestine) is the main enzyme responsible for lipid
absorption (70%) [231]. Pancreatic lipase releases fatty acids from sn1 and sn3 positions of dietary
triacylglycerols, yielding monoacylglycerols, diacylglycerols, and free fatty acids (Figure 1). It is a
50 kDa, 449-amino acid protein with two structural domains (Ct and Nt). The catalytic triad (Ser152,
Asp176, and His263) is located in the Nt domain, while the Ct domain contains the interaction site
with colipase [231]. Colipase is a small protein (10 kDa), also secreted by the pancreas, that acts as a
cofactor required for the activity of pancreatic lipase in the presence of bile salts. Colipase anchors
pancreatic lipase to the lipid/water interface of the micelles formed between bile salts and long-chain
triacylglycerols, allowing it to display its catalytic activity [236].
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4.5.2. Phenolics from Soybean and Chickpea as Inhibitors of α-amylase, α-glucosidase, and Lipase
Few studies have explored the inhibition of carbohydrate and lipid hydrolases by chickpea and
soybean phenolic compounds. Most have only worked with phenolic-rich extracts, and just a few
have thoroughly characterized the extracts and identified the bioactive compound(s). In Tables 5
and 6, the main findings of these studies, most of which have focused on α-glucosidase (Table 5) and
α-amylase (Table 6), are summarized.
The inhibition of both carbohydrate hydrolases (α-amylase and α-glucosidase) by phenolic
extracts of chickpea [125,127] and soybean [129,237] has been studied in the last decades. All these
studies found a similar inhibitory activity for both enzymes, except McCue et al. [237] who found
that soybean extracts were better inhibitors of α-amylase than α-glucosidase. The chickpea extract
studied by Sreerama et al. [119,127] contained phenolic acids and flavonoids, such as flavonols,
isoflavones, and proanthocyanidins, although the authors did not identify the most bioactive component
responsible for enzyme inhibition. The chickpea extract had lowerα-glucosidase inhibitory activity and
intermediate α-amylase inhibitory activity, compared with other legumes (cowpea [Vigna unguiculata]
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and horse gram [Macrotyloma uniflorum]), and it was a better inhibitor of both enzymes than the
soybean extracts studied by Ademiluyi and Oboh [129]. The studies of Sánchez-Magaña et al. [125]
and McCue et al. [237] showed that fermentation increased the enzyme inhibitory activity of chickpea
and soybean phenolic extracts, respectively.
Several studies have analyzed the inhibition of α-glucosidases by phenolic-rich chickpea and
soybean extracts. Yao et al. [131] compared the α-glucosidase inhibition (as a percentage) elicited by
phenolic-rich ethanolic extracts of chickpea, soybean, and other legumes, such as peas and different
kinds of beans. The chickpea extract was found to be a better α-glucosidase inhibitor than the
soybean extract, but both showed considerably lower activity than extracts of various bean species,
of which Adzuki bean (Vigna angularis) had the highest activity. The authors found no correlation
between α-glucosidase inhibition and phenolic acid content or antioxidant activity [131]. This lack
of correlation was also reported by Tiwari et al. [238], who studied the effect of sprouting on the
α-glucosidase inhibitory activity, antioxidant, and other biological activities of chickpea extracts.
Interestingly, the authors found mitigation of postprandial glycemic response in rats pretreated with
extracts (sprouted and non-sprouted) of one chickpea variety, but this effect was not correlated with
the α-glucosidase inhibitory activity [238]. In contrast, Lee et al. [132] did find a correlation between
phenolic content of soybean extracts obtained with different solvent polarity (different methanol
content, acetone, dichloromethane) and α-glucosidase inhibition. Authors observed the highest
α-glucosidase inhibitory activity in the 70% methanol extract (higher than acarbose, positive control),
which also presented the highest total phenol content and individual isoflavones (mainly glucosides,
malonylglucosides, and acetylglucosides). In another study, Lee et al. [239] evaluated the effect of
fermentation on ten varieties of soymilk over the inhibitory activity against α-glucosidase and lipase.
Fermentation increased the inhibitory activity toward both enzymes, and the authors observed a
correlation between total phenolic compounds and enzyme inhibition. As expected, upon fermentation,
glycosylated isoflavones content decreased while aglycone content increased. Other studies have
found that food products containing chickpea and soybean also possess α-glucosidase inhibitory
activity. Furthermore, treatments like cooking, sprouting, or fermentation generally increases the
capacity of the phenolics obtained from these feedstocks, inhibiting the activity of the aforementioned
enzyme [132,238–241]. None of the studies analyzed the inhibitory mechanisms of the extracts or
explored the molecular interactions between α-glucosidase and the chickpea or soybean bioactive.
Table 5. Inhibition of α-glucosidase by soybean and chickpea phenolic extracts.
Extraction Identification Methods Main Findings Reference
Chickpea 80% ethanol
for free phenolics,
NaOH hydrolysis for
bound phenolics
Free (93 mg GAE/100 g sample)
and bound (128 mg GAE/100 g
sample) phenolic compounds
α-glucosidase
inhibition index
(GI = control
activity/sample
activity)
GI of 1.23 and 1.71 for
free and bound phenolic
extracts, respectively.
Incubation of chickpea
flour with Rhizopus
oligosporus increased GI.
[125]
Chickpea 80%
methanol with 1% HCl
Phenolic acids: ferulic,
p-hydroxybenzoic,
protocatechuic, caffeic,
chlorogenic, and p-coumaric.
Flavonols: quercetin, kaempferol,
myricetin. Isoflavones: daidzein,
genistein, and genistein hexoside
Proanthocyanidins
Enzyme inhibition
(IC50)
IC50 = 92.2 µg/mL.
Lower activity compared
to underutilized Indian
legumes (horse gram
and cowpea).
[119,127]
Chickpea 70% ethanol
Ferulic acid (9.1 mg/100 g),
p-coumaric (4.5 mg/100 g),
sinapic acid (4.5 mg/100 g),
chlorogenic acid (0.13 mg/100 g)
Enzyme inhibition
(%), enzyme source
not specified
15.9% inhibition.
Lower inhibition
compared to beans and
peas, but higher than
soybean. No correlation
with phenolic acids nor
antioxidant capacity.
[131]
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Table 5. Cont.
Extraction Identification Methods Main Findings Reference
Chickpea 80% ethanol
for free phenolics,
NaOH hydrolysis for
bound phenolics
Free (72 mg GAE/100 g sample)
and bound (105 mg GAE/100 g
sample) phenolic compounds
Enzyme inhibition
(%), enzyme source
not specified
26 and 76% inhibition for
free and bound phenolic
extracts, respectively,
obtained from brownies
baked with chickpea
flour.
[241]
Chickpea 85%
methanol
Total phenolic compounds, total
flavonoids, total anthocyanins.
Rat intestinal
α-glucosidase
inhibition (%)
Between 16.2 and 43.6%
inhibition.
No correlation with and
phenolic content nor
antioxidant capacity.
Germination increased
inhibition.
[238]
Soybean free (80%
acetone) and bound
(4 M NaOH) phenol
extracts
Free (98 mg GAE/100 g sample)
and bound (77 mg GAE/100 g
sample)
Enzyme inhibition
(IC50)
IC50 = 373 and 458
µg/mL for free and
bound phenolic
compounds,
respectively.
[129]
Solid state
fermentation (SSF) and
germinated soybean
water extracts
3–5 mg catechin equivalents
(CE)/g for dry soybeans, 6–7 mg
CE/g SSF, 4.5 mg CE/g sprouted
soybean
α-glucosidase
(yeast) inhibition
index (GI = control
activity/sample
activity)
Approximately 1.1 GI for
SSF and sprouted
extracts. Less inhibition
compared to α-amylase.
[237]
Soybean 70% ethanol
Ferulic acid (14.69 mg/100 g),
sinapic acid (5.41 mg/100 g),
p-coumaric (1.45 mg/100 g),
caffeic acid 0.63 mg/100 g
Enzyme inhibition
(%), enzyme source
not specified
12.06% inhibition.
Lower inhibition
compared to chickpea,
beans, and peas.
No correlation with
phenolic acids nor
antioxidant capacity.
[131]
Acetone: water: acetic
acid soybean extract.
Fractionation of the
extract with Amberlite
XAD-7 resin
Total phenolic compounds, total
flavonoids, total condensed
tannins
Enzyme inhibition
(IC50)
IC50 = 75.4 and 5.4
µg/mL for crude and
tannin-rich extracts,
respectively.
Lower inhibition than
black bean extracts.
[242]
70% methanol soybean
phenolic extract
Total phenolic compounds
(2.1 mg GAE/g).
Glucosylated, molonylated,
acetylated, and aglycone
isoflavones: daidzein, genistein,
and glycitein
Enzyme inhibition
(%) of 1 mg/mL
extract solution
Different
methanol-water extracts
were obtained. 70% of
methanol showed the
highest phenolic,
isoflavone content,
and enzyme inhibition
(81%).
[132]
70% methanol
hydroxylated and
fermented soybean
milk phenolic extract
Total phenols (3.7–6.6 mg GAE/g
DW), total flavonoids
(0.1–0.3 mg RE/g DW).
Glucosylated and aglycone
isoflavones: daidzein, genistein,
and glycitein
Enzyme inhibition
(%) of 0.5 mg/mL
extract solution
10 different varieties of
soybean were analyzed.
Enzyme inhibition
between 32.4–55.5%.
Glucosylated isoflavones
decreased,
and aglycones increased.
[239]
Fermented soybean
water extract
Total phenolic compounds
(22.2–30.7 mg GAE/g)
Enzyme inhibition
(IC50)
Different fungal strains.
IC50 ranged between
27.4 and 41.0 mg/mL.
[240]
Solid state
fermentation (SSF) and
germinated soybean
water extracts
3–5 mg catechin equivalents/g
DW for dry soybeans, 6–7 mg
CE/g DW SSF, 4.5 mg CE/g DW
sprouted soybean
α-glucosidase
(yeast) inhibition
index (GI = control
activity/sample
activity)
Approximately
1.5–2.08 AI for SSF
extracts and 1.3 AI for
sprouted samples.
[237]
Abbreviations: GAE, gallic acid equivalent; CE, catechin equivalent; RE, rutin equivalent; DW, dry weight.
IC50, the concentration necessary to inhibit enzymatic activity by 50%.
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Table 6. Inhibition of α-amylase by soybean and chickpea phenolic extracts.
Extraction Identification Methods Main Findings Reference
Chickpea 80% ethanol
for free phenolics,
NaOH hydrolysis for
bound phenolics
Free (93 mg GAE/100 g
sample) and bound
(128 mg GAE/100 g
sample) phenolic
compounds
α-amylase inhibition
index (AI = control
activity/sample activity)
AI of 1.9 and 1.66 for free
and bound phenolic
extracts, respectively.
Incubation of chickpea
flour with Rhizopus
oligosporus increased AI.
Good correlation between
phenolics and AI.
[125]
Chickpea 80%
methanol with 1% HCl
Phenolic acids: ferulic,
p-hydroxybenzoic,
protocatechuic, caffeic,
chlorogenic,
and p-coumaric. Flavonols:
quercetin, kaempferol,
myricetin. Isoflavones:
daidzein, genistein,
and genistein hexoside
Proanthocyanidins
Enzyme inhibition (IC50) IC50 = 108.3 µg/mL. [119,127]
Chickpea water extract
Not identified (peptides
and/or phenolic
compounds)
Enzyme inhibition (%)
34% inhibition.
Lower inhibition
compared to fava beans,
peas, and lentils and
similar to beans.
Activity increased by
processing.
[245]
Chickpea water extract Not identified (probablypeptides) Enzyme inhibition (%)
No inhibition.
High activity in beans and
soybean, reduced by
soaking and cooking.
[243]
Chickpea protein
extracts
Not identified (probably
peptides)
Enzyme inhibition
(Units/g)
16 different varieties
evaluated for
antinutritional factors.
0–15 Units/g, average 8.7.
Activity lower than other
pulses decreases by
cooking.
[244]
Soybean free (80%
acetone) and bound
(4 M NaOH) phenol
extracts
Free (98 mg GAE/100 g
sample) and bound (77 mg
GAE/100 g sample)
Enzyme inhibition (IC50)
IC50 = 526 and 320 µg/mL
for free and bound
phenolic compounds,
respectively.
[129]
Acetone: water: acetic
acid soybean extract.
Fractionation of the
extract with Amberlite
XAD-7 resin
Total phenolic compounds,
total flavonoids, total
condensed tannins
Enzyme inhibition (IC50)
IC50 = 2.25 and
0.25 mg/mL for crude and
tannin-rich extracts,
respectively.
Higher inhibition than
black bean extracts.
[242]
Water soybean
phenolic extract
Not identified (probably
peptides)
Enzyme inhibition
(Units/g)
939 and 899 units/g dry
weight for raw and soaked
soybeans, respectively.
No inhibitory activity for
cooked samples.
[243]
Fermented soybean
water extracts
Total phenolic compounds
(2–12.7 mg CE/g DW),
glucosidated and aglycone
isoflavones: daidzein,
genistein
Enzyme activity
(units/g DW)
α-amylase activity
increased during
fermentation
(39.3–128.2 units/g DW)
depending on
fermentation time and
Bacillus species.
[246]
Abbreviations: GAE, gallic acid equivalent; CE, catechin equivalent; RE, rutin equivalent; DW, dry weight. IC50,
the concentration necessary to inhibit enzymatic activity by 50%.
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Most studies published to date on the inhibition ofα-amylase by chickpea extracts have used water
as a solvent and considered the presence of inhibitors as an antinutritional factor. However, the extracts
have generally shown low inhibition of α-amylase (as compared with other pulses, such as soybean
and other beans), which is further decreased by cooking, suggesting the presence of peptide inhibitors
and a low antinutritional potential of chickpea [243,244].
The work of Moussou et al. [245] found a moderate inhibitory activity of a chickpea water
extract, which was slightly enhanced by thermal treatment; therefore, although they did not identify
the inhibitory compounds in the extract, their heat-stability could indicate the presence of phenolic
compounds. The authors also highlighted the health-promoting potential of α-amylase inhibitors,
for their ability to avoid a rapid rise in postprandial glucose, which is a risk factor for the development
of diabetic complications, in opposition to their antinutritional effects, which would be evident only in
case of excessive α-amylase inhibition.
Shi et al. [243] compared the α-amylase inhibitory activity of aqueous extracts of chickpea, soybean,
and other pulses (peas, lentils, and beans) and found that only beans (Phaseolus vulgaris) and soybean
possessed this activity. The authors also found high protease inhibitory activity in the soybean extracts,
but this was due to the presence of inhibitory peptides, which are significantly degraded upon cooking [243].
Another study showed that the α-amylase inhibitory activity of soybean aqueous extracts increased during
fermentation, depending on the time of fermentation and the species of microorganism [246].
Inhibition of pancreatic lipase by chickpea and soybean has been less studied. In Table 7, the main
findings of these studies are summarized. Lee et al. [247] studied the inhibition of aqueous methanolic
extracts obtained from defatted chickpea and soybean flours. Although the authors did not identify
the bioactive compounds in the extract, aqueous methanol was one of the preferred solvents for the
extraction of phenolic compounds. The chickpea and soybean extracts showed similar EC50 values,
slightly lower than that of mung bean (Vigna radiata), but in the range of red bean (Vigna angularis) and
black-eyed pea (Vigna unguiculata). Interestingly, the activity of chickpea was not affected by simulated
in vitro digestion. Two studies that analyzed the effect of fermentation on soybean anti-lipase potential
found a decrease in glycosylated flavonoids (including isoflavones), an increase in isoflavone and
other flavonoid aglycones, and an increase in lipase inhibitory activity in the extracts of fermented
soy products [239,248]. This indicated that the anti-lipase activity of aglycones was superior to that
of glycosides.
Tan et al. [242] carried out a detailed study on the inhibition of the three digestive enzymes
(α-glucosidase, α-amylase, and lipase) by crude, semi-purified, and fractionated phenolic extracts,
as well as pure phenolic compounds of black soybean and other foods. They found that the soybean
crude and semi-purified extracts were among the most potent inhibitors of the three enzymes with
greater activity against α-glucosidase > lipase > α-amylase. In addition, some extract fractions rich in
total phenolic compounds, flavonoids, and condensed tannins were betterα-glucosidase andα-amylase
inhibitors than commercially available inhibitors. Correlations were found between total phenol and
total flavonoid content and IC50 values against α-glucosidase; and between condensed tannin content
and IC50 against α-amylase. The authors observed that phytochemical content and antioxidant activity
were not the only predictors for enzyme inhibition and suggested that some specific structures might
have a stronger inhibitory effect on certain enzymes [242].
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Table 7. Inhibition of α-glucosidase by soybean and chickpea phenolic extracts.
Extraction Identification Methods Main Findings Reference
Chickpea 80%
methanol with 1% HCl Not identified Enzyme inhibition (IC50)
IC50 extract: 6.3 mg/mL.
Higher activity than other
pulses. No effect of
in vitro digestion.
[247]
Fermented soybean
supplements 80%
methanol extract
75 ppm GAE
non-fermented extract.
160 ppm GAE 60 h
fermented extract.
Aglycone flavonoids and
isoflavones
Enzyme activity (% of
control). 10 mg/mL
extracts
Fermentation increased
lipase inhibition and
content of aglycone
flavonoids and
isoflavones.
[248]
Soybean 80% methanol
with 1% HCl Not identified Enzyme inhibition (IC50)
IC50 extract:
6.65–6.97 mg/mL.
Similar activity to
chickpea.
[247]
Acetone: water: acetic
acid soybean extract.
Fractionation of the
extract with Amberlite
XAD-7 resin
Total phenolic
compounds, total
flavonoids, total
condensed tannins
Enzyme inhibition (IC50)
IC50 = 0.27 and
0.081 mg/mL for crude and
flavonoids rich extracts,
respectively.
[242]
70% methanol
hydroxylated and
fermented soybean
milk phenolic extract
Total phenols
(3.7–6.6 mg GAE/g DW),
total flavonoids
(0.1–0.3 mg RE/g DW).
Glucosylated and
aglycone isoflavones:
daidzein, genistein,
and glycitein
Enzyme inhibition (%) of
0.5 mg/mL extract
solution
10 different varieties of
soybean were analyzed.
Enzyme inhibition
between ND–43.4%.
Glucosylated isoflavones
decreased, and aglycones
increased.
[239]
Abbreviations: GAE, gallic acid equivalent; RE, rutin equivalent; DW, dry weight. IC50, the concentration necessary
to inhibit enzymatic activity by 50%.
4.5.3. Phenolic Compounds and Digestive Enzymes and Their Structure-Activity Relationship (SAR)
As described in the previous section, the published studies regarding the inhibition of digestive
enzymes by chickpea and soybean phenolic compounds are scarce, and their inhibition results are
only reported as percentage of inhibition, half maximal inhibitory concentration (EC50), or enzymatic
inhibition index, without giving information on the inhibition kinetics or the mechanism of action.
However, considering the abundance of total and individual phenolic compounds found in chickpeas
and soybeans, it is possible to propose the mechanism of action of these phenolic compounds as
digestive enzyme inhibitors.
Some authors have summarized the possible mechanisms of action of phenolic compounds on the
inhibition of digestive enzymes. They have also proposed the main structure-activity relationship (SAR)
that regulates these inhibitory processes [231,249–254]. Even though, in some cases, semi-purified
extracts have been used to evaluate the inhibition patterns of phenolic compounds, in order to
propose the inhibitory mechanisms, it is preferable to evaluate the inhibitory activity of pure phenolic
compounds since synergistic or antagonistic effects can be observed among them or with other
compounds, such as sugars or organic acids, normally present in phenolic extracts, sometimes even at
higher concentrations than the phenolic compounds [250,255].
In general terms, it is accepted that the inhibitory activity of phenolic compounds against
digestive enzymes depends on two main factors: (i) structural characteristics of the enzyme, including
hydrophobicity, isoelectric point, size, and amino acid composition [252]. A higher inhibition of
α-amylase (55 kDa) than α-glucosidase (260 kDa) has been reported by some authors, suggesting that
the size of the enzyme plays an important role in their inhibition by phenolic compounds [125,256].
Phenolic compounds are more active toward carbohydrate-hydrolyzing enzymes, compared to lipases,
probably because lipases are active in a less polar environment [231]. Extraction solvent polarity
also plays an important role in enzyme inhibition by phenolic compounds. In this context, Benatti
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Justino et al. [257] reported that phenolic extracts obtained with low polarity solvents (butanol,
ethyl acetate) showed higher inhibitory activities toward the three digestive enzymes compared to
extracts obtained with polar solvents (water, ethanol). In another study, Tan et al. [242] observed
that while amylase and glucosidase enzymes were highly inhibited by condensed tannins extracted
from soybeans, lipase was better inhibited by flavonoids rich extracts. (ii) structural characteristics
of phenolic compounds, including molecular weight, number of hydroxyl groups, glycosylation,
and hydrogenation [231,252]. It has been extensively reported that phenolic acids show lower
inhibitory activity than flavonoids and that the activity of phenolic acids increases with the number
of hydroxyl groups present in their structure [231]. In the case of polymeric compounds (condensed
tannins), oligomeric structures (<10 monomeric units) show higher inhibitory activity compared to
polymeric structures (>10 monomeric units) and monomeric phenolic compounds, probably because
oligomeric structures are able to form specific interactions with the active site of the enzyme, while
bigger structures form non-specific interactions within all the enzyme surface [258] and monomeric
compounds form less or weaker interactions. Interestingly, a synergic effect of monomeric phenolic
compounds and condensed tannins with different degree of polymerization from black bean extracts
has been reported for the inhibition of α-amylase, α-glucosidase, and lipase [242].
In order to gain information on the inhibitory mechanism of action of phenolic compounds
against digestive enzymes, kinetic studies, in combination with other techniques, such as fluorescence
spectroscopy, calorimetric studies, and in silico analyses by molecular docking of pure compounds,
are necessary. The inhibition of digestive enzymes by phenolic compounds is mainly due to
spontaneous (∆G −) reversible non-covalent specific interactions [231,250], even though in the
case of high molecular weight proanthocyanidins (condensed tannins), non-specific covalent and
non-covalent interactions may occur [258]. Hydrophobic interactions, hydrogen bonds, van der
Waals, and electrostatic interactions are the main forces involved in the phenolic compounds-digestive
enzymes interactions [231,250]. Hydrophobic interactions (∆H +, ∆S +) occur mainly between two
aromatic groups (pi stacking interactions), one from the phenolic compound, and the second one from
an aromatic residue in the enzyme. van der Waals forces (∆H −, ∆S −) are present between the aromatic
ring of the phenolic compound and methyl groups or aliphatic chains in the enzyme. Hydrogen bonds
(∆H −, ∆S −) occur between hydroxyl groups from the phenolic compound and oxo or hydroxyl groups
in the enzyme. Finally, electrostatic interactions occur between hydroxyl groups from the phenolic
compound and charged amino groups from Lys or Arg residues [231,250]. The number and intensity
of these non-covalent interactions are regulated by physicochemical parameters, such as temperature,
solvent polarity, pH, and saline concentration.
The main inhibition mechanisms reported for phenolic compounds as inhibitors of digestive
enzymes is mixed-type inhibition, in which both competitive (ki) and non-competitive (ki’) components
are present [231,250,259,260], indicating that the phenolic compound may bind both near the binding
site and/or in another region of the enzyme and that they can bind both the free enzyme and the
enzyme-substrate complex. Flavonoids have shown mixed-type inhibition of both α-amylase and
lipase, in which the competitive component (inhibitor binds tighter with free enzyme) regulates the
process [259,260]. Similar results were observed for caffeic and p-coumaric acids with lipase [259].
Structure-activity relationship (SAR) is an analytical (qualitative or quantitative) technique
that allows us to determine the association between the structure of bioactive compounds to their
biological/chemical activities. For phenolic compounds, it has been used to determine the association
between their main structural characteristics (number and position of hydroxyl groups, number of
conjugated double bonds, methylation, glycation, galloylation) and their antioxidant, antiproliferative,
and enzyme inhibitory activities. SAR analysis combines the kinetic, spectroscopic, and in silico
modeling (molecular docking) results in order to better understand the main structural characteristics
of phenolic compounds that allow them to inhibit the digestive enzymes. With these studies, it is
possible to propose the binding site as well as the type of interaction present between the enzyme and
the different phenolic compounds.
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SAR analysis has been used mainly to describe the structural characteristics of flavonoid-enzyme
interactions, because, as previously described, phenolic acids showed lower inhibitory activity toward
digestive enzymes. Table 8 summarizes the main structural characteristics of flavonoids that affect
their inhibitory activity of α-amylase, α-glucosidase, and lipase [231,249–254,261].
As shown in Table 8, the unsaturation of the C2–C3 bond in combination with the 4-oxo group
(both in ring C), which provides rigidity and planarity to the flavonoid structure, increases the
inhibitory activity toward the three digestive enzymes. In this context, flavan-3-ol (catechin), which
lacks both the double bond at C2–C3 and 4-oxo group, showed neither lipase nor α-amylase inhibitory
activity [231,260].
Table 8. Structure-activity relationship of flavonoids-digestive enzymes inhibition.
Phenolics Structure α-amylase α-glucosidase Lipase
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-OMe ↓ ↓
-OGalloyl ↑ ↑ ↑
-Gly ↓ ↓ ↓ l
Ring B
O-Me ↓ ↑ ↑
Isoflavone -OH ↑ ↑ l
-Gly ↓ ↓
Flav: Flavonoid. Iso: Isoflavone. -Gly: Glycosylation. -OGalloyl: attachment of a galloyl moiety to the hydroxyl
group. ↑ increase in enzymatic inhibition. ↓ decrease in enzymatic inhibition. l No systematic effect; it can increase
or decrease the inhibitory activity depending on the flavonoid.
Increasing the number of hydroxyl groups in all rings is another relevant characteristic for enzyme
inhibition. This inhibitory effect is more evident when ortho diphenols (catechol) are present in the
structure. Substitution of hydroxyl groups in any of the rings for methoxy or glycoside moieties
drastically reduces the enzymatic activity due to the loss of hydrogen bonds and steric hindrance.
Interestingly, when this glycoside moiety is replaced by a phenolic acid (gallic acid), the α-glucosidase
activity of the flavonoids is increased [253]. Finally, the substitution of C3 hydroxyl group in ring C
of flavonoids by a galloyl moiety increases the enzymatic inhibition of the three digestive enzymes,
due to the increase in the number of hydroxyl groups in the molecule.
Few SAR studies have been carried out to evaluate the effect of isoflavones against digestive
enzymes [249,251,253,254,262]. Tadera et al. [262] reported lower inhibition of α-glucosidase than
α-amylase in the presence of daidzein (2 hydroxyl groups at positions 7 and 4’) and genistein (3 hydroxyl
groups at positions 5, 7, and 4’). They also observed that the inhibition of both enzymes was higher
with genistein, indicating that hydroxylation of isoflavone ring A increased the inhibitory activity
against α-amylase and α-glucosidase. In the case of ring B, no systematic effect of hydroxylation
was observed. Methoxylation of hydroxyl groups in all rings decreased the inhibitory activity of
isoflavones. The same effect was observed upon glycosylation of hydroxyl groups in ring C [253,254].
In order to confirm the structure-activity relationship and the mechanism of action of phenolic
compounds in digestive enzyme inhibition, in silico studies by molecular docking and molecular
potential analyses are performed. Docking analysis predicts the possible binding sites between phenolic
compounds and digestive enzymes [258,260]. For this, the minimal free energy change (∆G) and the
structure of ligand (phenolic compound)-protein complex is determined, in order to propose the most
favorable binding pockets and ligand conformation. Docking results predict the main interactions
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between amino acid residues with phenolic compounds, as well as the main non-specific covalent
interactions present in the complex formation. Docking results confirm that the main interactions
between digestive enzymes and monomeric phenolic compounds (phenolic acids and flavonoids)
occurred near the active site, through hydrophobic interactions, hydrogen bonds, van der Waals,
and electrostatic interactions, in agreement with kinetic and spectroscopic results. Interestingly, docking
results obtained between proanthocyanidin oligomers (heptamers) and α-amylase showed multiple
interaction sites with the surface of the enzyme through numerous hydrophobic interactions, instead of
one single interaction site with the catalytic cavity [258]. Similar results were obtained for the interaction
of proanthocyanidin oligomers with lipase. Trimer and tetramer proanthocyanidins interacted in the
lipase-colipase binding region through hydrogen bonding, resulting in a higher inhibition compared
to a heptamer proanthocyanidin, which interacted only with colipase in a region not critical for the
lipase-colipase union, necessary to catalyze the triacylglycerol hydrolysis [258].
From the analysis of the information given in the present review, it is evident that both chickpea
and soybean may inhibit digestive enzymes by the action of monomeric and polymeric phenolic
compounds present in their matrix. However, further studies are necessary in order to be able to identify
the individual inhibitory compounds and propose their mechanism of action against digestive enzymes,
as well as to evaluate the possible synergistic or antagonistic effect of these phenolic compounds
between them and with other molecules present in the extracts.
4.5.4. Prevention of Type 2 Diabetes and Obesity Beyond Inhibition of Digestive Enzymes
The evidence about chickpea in relation to obesity and diabetes prevention have mainly been
focused on the impact of the bioactive phenolic compounds (phenolic acids and flavonoids), bioactive
peptides, carotenoids, phytoesterols, and fermentable fibers [47]. In addition, soybean, chickpea,
and other legumes have a low glycemic index, which is important for patients with type 2 diabetes [263].
The proposed mechanisms of action of soybean, chickpea, and their bioactive compounds on insulin
resistance, obesity, and lipid metabolism are summarized in Figure 2 and Table 9.
Leptin, a hormone produced by adipose cells, modulates energy balance and inhibits hunger.
A decreased sensitivity to leptin in obesity jeopardizes detection of satiety even when high levels of
this hormone and high energy stores occur. Among the mechanisms listed in Figure 2, human evidence
on the role of soybean isoflavones in modulating sensitivity to leptin is still inconclusive [264–266]
and needs further investigation. Furthermore, to the best of our knowledge, there is still a gap in the
available literature with respect to the effects of isoflavones from chickpea.
Supplementation with soybean, chickpea, or their respective isoflavones can attenuate insulin
resistance, possibly by reducing adiposity [94,185]. Furthermore, non-alcoholic fatty liver disease
(NAFLD) is associated with an increase in the prevalence of obesity and diabetes [267]. The effects
of soy isoflavones on the development of NAFLD in animal models, as well as the mechanisms
involved (e.g., lipid metabolism, oxidative stress, and inflammation), were summarized by Van De
Wier et al. [268]. According to these authors, histological studies related to inflammation support the
anti-inflammatory effect of isoflavones. Finally, the same report suggests that clinical trials on the use
of soy isoflavones in NAFLD patients are still necessary.
Yang et al. [185] showed that chickpea attenuated hyperglycemic, hyperinsulinemic, visceral
adiposity, and lipid accumulation in rats induced by a chronic high-fat diet. Animal studies have shown
that soy protein and soy isoflavones could improve insulin sensitivity and glucose control [269–271],
and population studies suggested a lower risk of insulin resistance and type 2 diabetes [272,273].
A meta-analysis suggested an inverse association between soy food consumption (soy protein and
isoflavones) and risk of type 2 diabetes mellitus [274]. Post-menopausal women who consumed a
high soy diet had a lower body mass index and fasting insulin [275]. These protective effects can be
found, especially, in women probably because phytoestrogen is structurally similar to female hormone
estradiol with receptor-mediated estrogenic activity, and probably may affect insulin modulation [274].
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Figure 2. Proposed mechanisms of action for the reduction of insulin resistance by soybeans and
chickpeas. Abbreviations: ↓, decrease; ↑, increase; PPAR-γ, peroxisome proliferator-activated receptor-γ;
HOMA-IR, homeostasis model assessment-insulin resistance; LDL-c: low-density lipoprotein
cholesterol; HDL: high-density lipoprotein.
Several in vivo studies have reported the beneficial effect of daidzein and genistein intake in
the glycemic regulation among different animal models. A high-fat diet supplemented with soy
isoflavones (0.4%, w/w) reduced weight gain, improved glucose metabolism and insulin sensitivity,
reduced hepatic lipid accumulation, and increased gene expression of Cpt1α and Acox-1 associated
with lipid oxidation in C57BL/6J mice [276]. Genistein and daidzein showed to exert anti-diabetic effects
by modulating hepatic glucose (glucokinase, glucose-6-phosphate dehydrogenase) and lipid (fatty acid
synthase, carnitine palmitoyltransferase, β-oxidation), regulating enzyme activities in db/db mice [277].
Genistein and daidzein treatment for 9 weeks caused a reduction in fasting blood glucose with
concomitant decrease in plasma insulin and C peptide levels by down-regulating glucose-6-phosphate
dehydrogenase (G6PD), phosphoenolpyruvate carboxykinase, fatty acid β-oxidation, and carnitine
palmitoyltransferase activities, while up-regulating malic enzyme and G6PD activities in liver with
preservation of pancreatic β-cells in non-obese diabetic mice [278].
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Table 9. Chickpea, soybean, and isoflavones in the prevention of type 2 diabetes and obesity and
associated metabolic biomarkers in vivo.
Model Treatment (Dose; Duration) Main Findings Reference
Chickpea
Animal
Male rats were fed a standard; HFD; or an
HFD plus 10% raw crushed chickpea seeds
diet for 8 months
Chickpeas:
↓ HOMA-IR, postprandial hyperglycemia,
and hyperinsulinemia
↓ body and epididymal adipose tissues weight
- Improvement in the lipid profile (↓triacylglycerols,
↓LDL-c, and ↓LDL-c:HDL-c levels)
↓ leptin mRNA levels in epididymal adipose
[185]
Clinical trial
Hypocaloric balanced diet + 4 servings/week
of non-soybean legumes (lentils, chickpeas,
peas, and faba beans) for 8 weeks in obese
subjects
- Weight loss
↓ total cholesterol
↓MDA
[279]
Clinical trial
Inclusion of 728 g chickpea per week for
12 weeks in healthy subjects in a crossover
design
↓ serum total cholesterol [187]
Clinical trial
Chickpea diet (140 g of canned, drained
chickpeas, chickpea bread, and chickpea
biscuits) for 5 weeks in hypercholesterolemic
subjects in a randomized crossover design
↓ serum LDL-c and total cholesterol concentrations [186]
Clinical trial
Randomized crossover design in healthy
subjects:
- Acute: 200 g chickpea (cooked and drained)
↓ glucose and insulin responses acutely [280]
Clinical trial
Inclusion of 728 g chickpea per week for
12 weeks in healthy subjects in a crossover
design
↓ fasting insulin concentration and HOMA-IR [187]
Soybean
Clinical trial
70 patients with type 2 diabetes were
randomly divided: test group (35 people)
with 60 g soy nut and control group
(35 people) under the usual diet of diabetes
for 8 weeks
↓ fasting blood glucose
↓ total serum cholesterol, LDL-c, and E-Selectin
↑ the capacity of serum total antioxidants
[189]
Clinical trial
Randomized, double-blind, cross-over trial
with 32 postmenopausal women with
diet-controlled type 2 diabetes, supplemented
with soy (30 g protein/day, 132 mg
isoflavones/day) for 12 weeks
↓ fasting insulin, insulin resistance, glycated
hemoglobin
↓ total cholesterol, LDL-c, cholesterol/HDL-c ratio
- No differences in HDL-c, triacylglycerols, weight,
blood pressure
[190]
Clinical trial
Randomized crossover clinical trial with
42 postmenopausal women with metabolic
syndrome. Participants assigned to consume
a control diet, a soy-protein diet, or a soy-nut
diet each for 8 weeks.
↓ insulin resistance, fasting plasma glucose
↓ LDL-c
↓ serum C-peptide
[191]
Clinical trial
Diabetic patients (n = 77) were randomized
prospective to the two treatments for
12 months: soy-based meal replacement,
or individualized diet plan
Soy-based meal replacement presented greater
values compared to the individualized diet plan:
- ↓weight
- ↓ fasting plasma glucose at 6 months
- ↓ glycated hemoglobin A1c
- ↓medications
- ↓ high sensitivity C-reactive protein at 6 months
[281]
Animal
Soy isoflavone supplementation (0.1% w/w)
of lean and obese spontaneously
hypertensive rat/N-corpulent rats
Soy isoflavone: ↓ body weight of obese rats
↓ peri-renal, epididymal, and subdiaphragmatic fat
pad weights in lean and obese rats
↓ ileal fat pads in obese rats
[282]
Animal
HFD-induced insulin resistant rats treated
with soy isoflavone with three different
dosages (50 mg, 150 mg, and 450 mg/kg/day)
for 30 days
↓ fat pad weights
↓ fasting insulin and HOMA-IR
↑ plasma and mRNA adiponectin and leptin levels,
↓ resistin levels
[283]
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Table 9. Cont.
Model Treatment (Dose; Duration) Main Findings Reference
Genistein and daidzein
Animal
Healthy normal mice divided into groups
and intraperitoneally administered: dimethyl
sulfoxide (DMSO) (control group) and
genistein (50 mg/kg + 10% DMSO).
Alloxan-induced diabetic male mice were
treated with DMSO 10% and genistein
(50 mg/kg + 10% DMSO)
Genistein: ↓ fasting glucose levels
↓ PEPCK-C expression
↑ AMPK and ERK 1/2 phosphorylation states in the
liver
[284]
Animal
C57BL/6J mice were fed: low-fat diet;
western-style diet, and western-style diet +
0.16% (w/w) of genistein or daidzein for
10 weeks.
Genistein and daidzein: ↓ food intake
↓ body weight gain
- Induced LXR-mediated pathways
[276]
Abbreviations: ↓, decrease; ↑, increase; HFD, high-fat diet; HOMA-IR, homeostasis model assessment-insulin
resistance; MDA, malondialdehyde; PEPCK-C, Phosphoenolpyruvate carboxykinase; AMPK, activated protein
kinase; ERK 1/2, extracellular signal-regulated kinase 1/2; LXR, Liver X Receptor.
Many studies have reported regulatory mechanisms of isoflavones on glucose tolerance, insulin
secretion, and pancreatic β-cells in streptozotocin (STZ)-induced diabetic rats. El-Kordy and
Alshahrani [285] demonstrated a protective and regenerative effect of genistein on pancreatic β-cell
damage and improvement in serum levels of insulin and glucose in STZ-induced diabetic rats in a
dose-dependent manner. Isolated soy protein and genistein were shown to regulate hyperglycemia in
STZ-induced diabetic rats [152]. Another study also demonstrated the effect of genistein on glycemia,
glucose tolerance, and insulin levels in STZ-induced diabetic mice [286]. Wright et al. [287] suggested
that genistein has a direct inhibitory effect on GLUT4 in rat adipocytes and soleus muscles.
Dietary soy isoflavone supplementation (genistein, daidzein, and glycitein 0.1% w/w) reduced fat
deposition in an animal model of obesity and diabetes [282]. Administration of soybean isoflavones
(150 and 450 mg/kg) in rats lowered fasting insulin levels and HOMA-IR, reduced total white adipose
tissue weight, lowered plasma resistin levels, and increased circulating protein and mRNA levels of
adiponectin in perirenal white adipose tissue compared to the insulin resistant control group [283].
Furthermore, according to the same study [283], the higher supplementation dose of soy isoflavones
(450 mg/kg/day) increased circulating protein and adipose mRNA levels of leptin and lowered adipose
mRNA levels of resistin compared to the insulin resistant control group.
Higher risk for obesity and insulin resistance due to the decline of estrogen has been reported in
postmenopausal women [288]. However, phytoestrogens (e.g., isoflavones) may reduce the risk of these
metabolic diseases. Accordingly, Choi et al. [268] investigated the effect of genistein supplementation
(0.1%, w/w) in a high-fat diet ovariectomized rats. Treated rats showed smaller-sized adipocytes and
decreased HOMA-IR index, reaching levels comparable to those of the non-ovariectomized group [288].
In addition, genistein supplementation resulted in the reduction of hepatic fatty acid synthase activity,
fatty acid synthesis genes, and showed an up-regulation in carnitine palmitoyltransferase, β-oxidation,
succinate dehydrogenase activity, and fat utilization genes [288].
Peroxisome proliferator-activated receptor (PPAR) and their subtypes (alpha, beta, gamma) are
related to insulin sensitivity [289]. PPAR-γ from adipose tissue indirectly modulates glucose and
lipid homeostasis due to its regulation of adipocyte differentiation [290]. It has been suggested that
chickpeas and soybeans isoflavones can down-regulate PPAR-γ, preventing the development of large
and dysfunctional adipocytes that occurs in obesity and insulin resistance [291]. Luo et al. [276]
evaluated the effect of soy isoflavones (genistein and daidzein) on C57BL/6J mice fed with a low-fat
diet, western diet (WD), WD + 0.16% (w/w) of genistein or daidzein. Genistein and daidzein
decreased food intake, body weight gain and induced liver X Receptor (LXR)-mediated pathways.
Furthermore, a higher reduction of energy intake (26%) was found in genistein-treated mice compared
to that of daidzein (8%). According to these authors, the reduction of food intake may stem from
the activation of transcription factor PPARα due to genistein and daidzein intake. PPARα agonist
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transiently decreases the intake of food. In addition, reduced food intake associated with PPARα
agonist treatment may be associated with cholecystokinin (CCK)-A receptor production. CCK is
secreted from duodenal and jejunal mucosal cells in response to the intake of fat and protein. CCK has
several physiological effects, including slowing gastric emptying and suppressing energy intake.
Phosphoenolpyruvate carboxykinase (PEPCK) activity regulate normal blood glucose levels and
has been shown to be increased in diabetic animal models. Dkhar et al. [284] investigated the effect
of genistein on the expression of PEPCK and glucose production in alloxan-induced diabetic mice.
Genistein (50 mg/kg body weight) reduced fasting glucose levels, PEPCK-C expression and increased
AMPK and ERK1/2 phosphorylation states in the liver of the genistein-treated alloxan-induced diabetic
mice [284]. The same study also showed that glucose production in HepG2 cells was reduced by about
50% in cells treated with genistein (30 µM).
Epidemiological and prospective studies have shown the beneficial effects of soy-foods
consumption in lowering the incidence of diabetes type 2 [292–294]. A randomized, cross-over,
double-blinded trial of dietary supplementation with soy phytoestrogens in postmenopausal women
resulted in lower values for fasting insulin, insulin resistance, and glycated hemoglobin A1c, when
compared with placebo [190]. Soybean inclusion in the diet decreased insulin resistance and fasting
plasma glucose in a randomized cross-over clinical trial with postmenopausal women with metabolic
syndrome [191]. Li et al. [281] compared the effects of a soy-based meal replacement versus an
individualized diet plan on weight loss and metabolic profile in diabetic patients randomized to
treatment. The soy-based group underwent a greater weight loss, fasting plasma glucose (6 months),
glycated hemoglobin A1c, and high sensitivity C-reactive protein. Furthermore, a greater number of
subjects in a soy-based meal replacement group reduced their use of sulfonylureas and metformin as
compared to the individualized diet plan. Medications, such as anti-hyperglycemic, are provided by
the government in some places like Brazil [295]. Therefore, by improving health and reducing the use
of anti-hyperglycemic medications, the inclusion of functional foods in the diet may also be helpful to
overcome an eventual economic burden.
High serum concentrations of soluble E-selectin have been found to correlate with obesity in
patients with type 2 diabetes mellitus [169]. Human intervention studies focusing on the health effects
of chickpea and its components are also available in the literature. Incorporation of chickpeas in
the diet reduced serum total fasting insulin concentration and HOMA-IR in healthy subjects [187].
Chickpea-based meal led to a lower glucose and insulin response in an acute consumption compared
with a wheat-based meal [280]. A systematic review and meta-analysis of randomized controlled
experimental trials in people with and without diabetes were carried out by Sievenpiper et al. [296].
According to these authors, pulses alone or in low-glycemic-index or high-fiber diets improve markers
of longer-term glycemic control in humans.
Polyphenols can also play a role by modulating gut microbiota in such a prebiotic-like effect [23,297].
In addition, the literature has shown that the addition of excess fructooligosaccharide (FOS) may
preserve genistein in human gut microflora in vitro [298]. Guadamuro [299] suggested that isoflavones
may act as an alternative energy source, thus increasing the production of equol and short-chain fatty
acids (SCFA), which are pivotal bacterial metabolites related to intestinal health benefits. The possible
role of SCFA on specific receptors that influence gut epithelial, enteroendocrine, and pancreatic
β-cells, as well as blood and renal vessels, adipose tissue, and peripheral nervous system, has been
summarized by Li et al. [300]. Therefore, as sources of isoflavones, chickpea and soybean may promote
the secretion of SCFA and, hence, their potential benefits do not rely only on the release of bioavailable
isoflavones in the plasma and other organs but also in indirectly mediating receptors related to several
chronic ailments.
5. Conclusions
Isoflavones as aglycones are usually more bioavailable than their conjugated counterparts.
Furthermore, the literature has supported their higher antioxidant activity compared to that of their
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conjugates. The contents of daidzein and genistein in chickpeas are comparable to the concentrations
reported in soybeans, which suggests that this legume seed may potentially substitute soybeans as a
source of isoflavone aglycones. Contrary to soybean, there is very little information in the literature
on the role of genetics with respect to the polyphenolic composition of chickpea, and, to the best of
our knowledge, there is no study associated with the genetic regulation of isoflavones in chickpea
seeds. Much has been discussed about the role of oxidative stress and inflammation in several chronic
ailments, and we have demonstrated that both legumes show antioxidant and anti-inflammatory
potential. Hence, their ability in preventing cardiovascular diseases and certain types of cancer appears
to be irrefutable. In contrast, due to their lower lipid content, chickpea seems to offer a better option in
weight management and prevention of type 2 diabetes. Several biomarkers related to these two diseases
were discussed, and the effect of isoflavones in inhibiting digestive enzymes must be better clarified.
Likewise, among the mechanisms discussed, human evidence on the role of soybean isoflavones in
modulating sensitivity to leptin is still inconclusive, which warrants further investigation.
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